Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 334

1.

Certolizumab pegol for the treatment of psoriatic arthritis.

Baronaite Hansen R, Kavanaugh A.

Expert Rev Clin Immunol. 2015 Mar;11(3):307-18. doi: 10.1586/1744666X.2015.1009897. Epub 2015 Feb 5.

PMID:
25651776
[PubMed - in process]
2.

Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis.

Kavanaugh A, Mease PJ, Gomez-Reino JJ, Adebajo AO, Wollenhaupt J, Gladman DD, Hochfeld M, Teng LL, Schett G, Lespessailles E, Hall S.

J Rheumatol. 2015 Mar;42(3):479-88. doi: 10.3899/jrheum.140647. Epub 2015 Jan 15.

PMID:
25593233
[PubMed - in process]
Free Article
3.

Concepts of pathogenesis and emerging treatments for inflammatory arthritis.

van Laar JM, Kavanaugh A.

Best Pract Res Clin Rheumatol. 2014 Aug;28(4):537-8. doi: 10.1016/j.berh.2014.11.001. No abstract available.

PMID:
25481547
[PubMed - in process]
4.

Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry.

Kavanaugh A, Lee SJ, Curtis JR, Greenberg JD, Kremer JM, Soto L, Etzel CJ, Cox V, Yoshida K, Reed GW, Solomon DH.

Ann Rheum Dis. 2014 Dec 3. pii: annrheumdis-2014-206435. doi: 10.1136/annrheumdis-2014-206435. [Epub ahead of print]

PMID:
25471471
[PubMed - as supplied by publisher]
5.

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.

Boyle DL, Soma K, Hodge J, Kavanaugh A, Mandel D, Mease P, Shurmur R, Singhal AK, Wei N, Rosengren S, Kaplan I, Krishnaswami S, Luo Z, Bradley J, Firestein GS.

Ann Rheum Dis. 2014 Nov 14. pii: annrheumdis-2014-206028. doi: 10.1136/annrheumdis-2014-206028. [Epub ahead of print]

PMID:
25398374
[PubMed - as supplied by publisher]
Free Article
6.

Proceedings from the american college of rheumatology reproductive health summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.

Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):313-25. doi: 10.1002/acr.22516. No abstract available.

PMID:
25385050
[PubMed - in process]
7.

Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.

Pincus T, Braun J, Kavanaugh A, Smolen JS.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-1. Epub 2014 Oct 30. No abstract available.

PMID:
25365080
[PubMed - indexed for MEDLINE]
8.

Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group.

Armstrong AW, Tuong W, Love TJ, Carneiro S, Grynszpan R, Lee SS, Kavanaugh A.

J Rheumatol. 2014 Nov;41(11):2306-14. doi: 10.3899/jrheum.140881.

PMID:
25362716
[PubMed - in process]
9.

Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.

Coates LC, Kavanaugh A, Ritchlin CT; GRAPPA Treatment Guideline Committee.

J Rheumatol. 2014 Nov;41(11):2273-6. doi: 10.3899/jrheum.140875.

PMID:
25362710
[PubMed - in process]
10.

A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist.

Genovese MC, van der Heijde DM, Keystone EC, Spindler AJ, Benhamou C, Kavanaugh A, Fudman E, Lampl K, O'Brien C, Duffield EL, Poiley J, Weinblatt ME.

J Rheumatol. 2014 Nov;41(11):2120-8. doi: 10.3899/jrheum.140238. Epub 2014 Sep 15.

PMID:
25225285
[PubMed - in process]
11.

Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Weinblatt ME, Genovese MC, Ho M, Hollis S, Rosiak-Jedrychowicz K, Kavanaugh A, Millson DS, Leon G, Wang M, van der Heijde D.

Arthritis Rheumatol. 2014 Dec;66(12):3255-64. doi: 10.1002/art.38851.

PMID:
25223724
[PubMed - indexed for MEDLINE]
12.

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

Dennis G Jr, Holweg CT, Kummerfeld SK, Choy DF, Setiadi AF, Hackney JA, Haverty PM, Gilbert H, Lin WY, Diehl L, Fischer S, Song A, Musselman D, Klearman M, Gabay C, Kavanaugh A, Endres J, Fox DA, Martin F, Townsend MJ.

Arthritis Res Ther. 2014;16(2):R90. Epub 2014 Apr 30.

PMID:
25167216
[PubMed - in process]
Free PMC Article
13.

Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?

Emery P, Kavanaugh A, Bao Y, Ganguli A, Mulani P.

Ann Rheum Dis. 2014 Aug 19. pii: annrheumdis-2014-205302. doi: 10.1136/annrheumdis-2014-205302. [Epub ahead of print]

PMID:
25139667
[PubMed - as supplied by publisher]
Free Article
14.

Psoriatic arthritis: current therapy and future approaches.

Huynh D, Kavanaugh A.

Rheumatology (Oxford). 2015 Jan;54(1):20-8. doi: 10.1093/rheumatology/keu237. Epub 2014 Aug 14.

PMID:
25125588
[PubMed - in process]
15.

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.

Landewé RB, Smolen JS, Weinblatt ME, Emery P, Dougados M, Fleischmann R, Aletaha D, Kavanaugh A, van der Heijde D.

Ann Rheum Dis. 2014 Oct;73(10):1755-60. doi: 10.1136/annrheumdis-2014-205821. Epub 2014 Aug 11.

PMID:
25114058
[PubMed - indexed for MEDLINE]
16.

A review of disease activity measures for psoriatic arthritis: what is the best approach?

Her M, Kavanaugh A.

Expert Rev Clin Immunol. 2014 Sep;10(9):1241-54. doi: 10.1586/1744666X.2014.943663. Epub 2014 Aug 4.

PMID:
25088300
[PubMed - in process]
17.

Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1759-66. doi: 10.1002/acr.22404. Review. No abstract available.

PMID:
25047391
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Novel treatments with small molecules in psoriatic arthritis.

Hansen RB, Kavanaugh A.

Curr Rheumatol Rep. 2014;16(9):443. doi: 10.1007/s11926-014-0443-6. Review.

PMID:
25027606
[PubMed - indexed for MEDLINE]
19.
20.

GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting.

Coates LC, Ritchlin CT, Kavanaugh AF.

J Rheumatol. 2014 Jun;41(6):1237-9. doi: 10.3899/jrheum.140179.

PMID:
24882861
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk